Liu G, Li B, Qin S, Nice E, Yang J, Yang L
Cell Oncol (Dordr). 2023; 47(2):429-445.
PMID: 37792154
DOI: 10.1007/s13402-023-00884-9.
Abrahams C, Woudberg N, Lecour S
Lipids Health Dis. 2022; 21(1):85.
PMID: 36050733
PMC: 9434835.
DOI: 10.1186/s12944-022-01694-y.
Sahu K, Langeh U, Singh C, Singh A
Curr Res Pharmacol Drug Discov. 2021; 2:100047.
PMID: 34909674
PMC: 8663961.
DOI: 10.1016/j.crphar.2021.100047.
Tasdogan A, Ubellacker J, Morrison S
Cancer Discov. 2021; 11(11):2682-2692.
PMID: 34649956
PMC: 8563381.
DOI: 10.1158/2159-8290.CD-21-0558.
Miguez A, Barros B, de Souza J, da Costa C, Cunha I, Barbosa P
Cancer Med. 2020; 9(16):5948-5959.
PMID: 32592321
PMC: 7433816.
DOI: 10.1002/cam4.3236.
Endovascular Ion Exchange Chemofiltration Device Reduces Off-Target Doxorubicin Exposure in a Hepatic Intra-arterial Chemotherapy Model.
Yee C, McCoy D, Yu J, Losey A, Jordan C, Moore T
Radiol Imaging Cancer. 2020; 1(1):e190009.
PMID: 32300759
PMC: 7134535.
DOI: 10.1148/rycan.2019190009.
Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate.
Abushouk A, Salem A, Saad A, Afifi A, Afify A, Afify H
Front Pharmacol. 2019; 10:635.
PMID: 31258475
PMC: 6586740.
DOI: 10.3389/fphar.2019.00635.
Synthesis of (±)-Idarubicinone via Global Functionalization of Tetracene.
Dennis D, Okumura M, Sarlah D
J Am Chem Soc. 2019; 141(26):10193-10198.
PMID: 31244190
PMC: 7305690.
DOI: 10.1021/jacs.9b05370.
The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment....
Ren X, Keeney J, Miriyala S, Noel T, Powell D, Chaiswing L
Free Radic Biol Med. 2018; 134:1-8.
PMID: 30593843
PMC: 6588453.
DOI: 10.1016/j.freeradbiomed.2018.12.029.
Protein phosphatase 5 and the tumor suppressor p53 down-regulate each other's activities in mice.
Wang J, Shen T, Zhu W, Dou L, Gu H, Zhang L
J Biol Chem. 2018; 293(47):18218-18229.
PMID: 30262665
PMC: 6254348.
DOI: 10.1074/jbc.RA118.004256.
Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment ("chemobrain").
Keeney J, Ren X, Warrier G, Noel T, Powell D, Brelsfoard J
Oncotarget. 2018; 9(54):30324-30339.
PMID: 30100992
PMC: 6084398.
DOI: 10.18632/oncotarget.25718.
Doxorubicin-induced renal inflammation in rats: Protective role of .
Entezari Heravi N, Hosseinian S, Yazd Z, Shafei M, Ebrahimzadeh Bideskan A, Shahraki S
Avicenna J Phytomed. 2018; 8(2):179-187.
PMID: 29632849
PMC: 5885332.
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells.
Huun J, Gansmo L, Mannsaker B, Iversen G, Ovrebo J, Lonning P
BMC Cell Biol. 2017; 18(1):17.
PMID: 28415963
PMC: 5393014.
DOI: 10.1186/s12860-017-0134-z.
Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF-7 breast cancer cell line.
Bober P, Alexovic M, Talian I, Tomkova Z, Viscorova Z, Benckova M
J Cancer Res Clin Oncol. 2016; 143(1):35-42.
PMID: 27620743
DOI: 10.1007/s00432-016-2259-4.
Superoxide induces protein oxidation in plasma and TNF-α elevation in macrophage culture: Insights into mechanisms of neurotoxicity following doxorubicin chemotherapy.
Keeney J, Miriyala S, Noel T, Moscow J, St Clair D, Butterfield D
Cancer Lett. 2015; 367(2):157-61.
PMID: 26225838
PMC: 4543408.
DOI: 10.1016/j.canlet.2015.07.023.
Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells.
Cao B, Li M, Zha W, Zhao Q, Gu R, Liu L
Metabolomics. 2013; 9(5):960-973.
PMID: 24039617
PMC: 3769585.
DOI: 10.1007/s11306-013-0517-x.
Late morfofunctional alterations of the Sertoli cell caused by doxorubicin administered to prepubertal rats.
Brilhante O, Okada F, Sasso-Cerri E, Stumpp T, Miraglia S
Reprod Biol Endocrinol. 2012; 10:79.
PMID: 22967030
PMC: 3502149.
DOI: 10.1186/1477-7827-10-79.
Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative.
Walker L, Perkins E, Kratz F, Raucher D
Int J Pharm. 2012; 436(1-2):825-32.
PMID: 22850291
PMC: 3465682.
DOI: 10.1016/j.ijpharm.2012.07.043.
Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain.
Joshi G, Aluise C, Cole M, Sultana R, Pierce W, Vore M
Neuroscience. 2010; 166(3):796-807.
PMID: 20096337
PMC: 2852883.
DOI: 10.1016/j.neuroscience.2010.01.021.
Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats.
Konat G, Kraszpulski M, James I, Zhang H, Abraham J
Metab Brain Dis. 2008; 23(3):325-33.
PMID: 18690526
DOI: 10.1007/s11011-008-9100-y.
